[Efficacy, safety and cost of eribulin in patients with metastatic breast cancer]

MLA

Marie-Justine, Paillard, et al. “[Efficacy, Safety and Cost of Eribulin in Patients with Metastatic Breast Cancer].” Bulletin Du Cancer, vol. 102, no. 9, Aug. 2014. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........6768c065d739c659c112ec568ae1acb7&authtype=sso&custid=ns315887.

APA

Marie-Justine, P., Elsa, C., Erion, D., Laura, M., Fernando, B., Cristian, V., Loïc, C., Philippe, M., Nathalie, M., Antoine, T.-V., Virginie, N., & Xavier, P. (2014). [Efficacy, safety and cost of eribulin in patients with metastatic breast cancer]. Bulletin Du Cancer, 102(9).

Chicago

Marie-Justine, Paillard, Curtit Elsa, Dobi Erion, Mansi Laura, Bazan Fernando, Villanueva Cristian, Chaigneau Loïc, et al. 2014. “[Efficacy, Safety and Cost of Eribulin in Patients with Metastatic Breast Cancer].” Bulletin Du Cancer 102 (9). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........6768c065d739c659c112ec568ae1acb7&authtype=sso&custid=ns315887.